Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/25414
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
THE INTERLEUKIN-17 (IL-17) PUZZLE IN CHAGAS’ DISEASE
Trypanosoma cruzi
Insuficiência cardíaca
Humanos
Infecção
Afiliación
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunologia Clínica. Rio de Janeiro, RJ, Brasil / Faculty of Medicine of Petrópolis. Petrópolis, RJ, Brazil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Salvador, BA, Brasil
Resumen en ingles
In this article, we discuss an alternative explanation for the fact that the production
and plasma levels of IL-17 are diminished in patients chronically infected with
Trypanosoma cruzi, suffering from congestive heart failure. This alternate hypothesis
considers the inhibitory pharmacological action of digoxin, a drug commonly used to
treat heart failure. We believe this is a significant point to be further studied as IL-17
was initially considered to be heart-protective. Therefore, our argument has profound
therapeutic implications
Palabras clave en portugues
Doença de ChagasTrypanosoma cruzi
Insuficiência cardíaca
Humanos
Infecção
Compartir